Cullinan Therapeutics, Inc. held its Annual Meeting of Stockholders on June 12, 2025, where stockholders elected three directors and ratified KPMG LLP as the accounting firm for the fiscal year 2025. Additionally, they approved executive compensation and decided on annual frequency for future advisory votes.